{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T15:48:18Z","timestamp":1791388098106,"version":"4.3.3"},"reference-count":43,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2005,12,1]],"date-time":"2005-12-01T00:00:00Z","timestamp":1133395200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Surgical Research"],"published-print":{"date-parts":[[2005,12]]},"DOI":"10.1016\/j.jss.2005.02.030","type":"journal-article","created":{"date-parts":[[2005,5,11]],"date-time":"2005-05-11T11:49:23Z","timestamp":1115812163000},"page":"172-175","source":"Crossref","is-referenced-by-count":27,"title":["Effect of Pre-Operative Short Course Famotidine on Tumor Infiltrating Lymphocytes in Colorectal Cancer: A Double Blind, Placebo Controlled, Prospective Randomized Study"],"prefix":"10.1016","volume":"129","author":[{"given":"Sorabh","family":"Kapoor","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sujoy","family":"Pal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peush","family":"Sahni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Siddharth","family":"DattaGupta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tushar","family":"Kanti Chattopadhyay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jss.2005.02.030_bib1","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1016\/S0140-6736(87)90552-6","article-title":"A new prognostic classification of rectal cancer","volume":"1","author":"Jass","year":"1987","journal-title":"Lancet"},{"key":"10.1016\/j.jss.2005.02.030_bib2","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1016\/0046-8177(94)90122-8","article-title":"From Duke\u2019s through Jass","volume":"25","author":"Harrison","year":"1994","journal-title":"Hum. Pathol."},{"key":"10.1016\/j.jss.2005.02.030_bib3","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1002\/(SICI)1096-9896(199707)182:3<318::AID-PATH862>3.0.CO;2-6","article-title":"Prognostic value of tumor infiltrating lymphocytes (TILS) in colorectal cancer","volume":"182","author":"Ropponen","year":"1997","journal-title":"J. Pathol."},{"key":"10.1016\/j.jss.2005.02.030_bib4","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1038\/bjc.1974.233","article-title":"Lymphoreticular infiltrate in human tumors, prognostic and biological implications. A review","volume":"30","author":"Underwood","year":"1994","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.jss.2005.02.030_bib5","first-page":"356","article-title":"Tumor infiltrating lymphocytes. Insight into tumor immunology and potential therapeutic benefits","volume":"6","author":"Yoong","year":"1996","journal-title":"Immunol."},{"key":"10.1016\/j.jss.2005.02.030_bib6","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/1097-0142(19910701)68:1<1::AID-CNCR2820680102>3.0.CO;2-K","article-title":"Continuous interleukin-2 and tumor infiltrating lymphocytes as treatment of advanced melanoma. A National Biotherapy Study Group Trial","volume":"68","author":"Dillman","year":"1991","journal-title":"Cancer"},{"key":"10.1016\/j.jss.2005.02.030_bib7","first-page":"1199","article-title":"Clinical results and characterisation of tumor infiltrating lymphocytes with or without recombinant interleukin-2 in human metastatic renal cell carcinoma","volume":"51","author":"Bukowski","year":"1991","journal-title":"Cancer Res."},{"key":"10.1016\/j.jss.2005.02.030_bib8","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1007\/BF01518519","article-title":"Inhibition of prostaglandin E2 formation and histamine action in cancer immunotherapy","volume":"3","author":"Uotila","year":"1993","journal-title":"Immunol. Immunother."},{"key":"10.1016\/j.jss.2005.02.030_bib9","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/0091-6749(84)90353-1","article-title":"Histamine induced suppressor cell activity","volume":"73","author":"Beer","year":"1984","journal-title":"J. Clin. Immunol."},{"key":"10.1016\/j.jss.2005.02.030_bib10","doi-asserted-by":"crossref","first-page":"357","DOI":"10.4049\/jimmunol.130.1.357","article-title":"Histamine induced suppressor factor (HSF)","volume":"130","author":"Garovoy","year":"1983","journal-title":"J. Immunol."},{"key":"10.1016\/j.jss.2005.02.030_bib11","doi-asserted-by":"crossref","first-page":"2456","DOI":"10.4049\/jimmunol.136.7.2456","article-title":"Histamine induced suppressor factor inhibition of NK cells","volume":"136","author":"Nair","year":"1985","journal-title":"J. Immunol."},{"key":"10.1016\/j.jss.2005.02.030_bib12","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1126\/science.190677","article-title":"Selective display of histamine receptors on lymphocytes","volume":"195","author":"Roszokowski","year":"1997","journal-title":"Science"},{"key":"10.1016\/j.jss.2005.02.030_bib13","first-page":"87","article-title":"Evidence of a dual role of endogenous histamine in angiogenesis","volume":"76","author":"Norrby","year":"1995","journal-title":"Int. J. Exp. Pathol."},{"key":"10.1016\/j.jss.2005.02.030_bib14","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1111\/j.1699-0463.1997.tb00590.x","article-title":"Angiogenesis new aspects to its initiation and control","volume":"105","author":"Norrby","year":"1997","journal-title":"APMIS"},{"key":"10.1016\/j.jss.2005.02.030_bib15","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1038\/sj.bjp.0704372","article-title":"Enhancement by histamine of vascular endothelial growth factor production in granulation tissue via H2 receptors","volume":"134","author":"Ghosh","year":"2001","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.jss.2005.02.030_bib16","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1007\/BF02148852","article-title":"Cimetidine as adjuvant treatment in colorectal cancer","volume":"38","author":"Svendsen","year":"1995","journal-title":"Dis. Colon Rectum"},{"key":"10.1016\/j.jss.2005.02.030_bib17","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/S0140-6736(95)92136-2","article-title":"Cimetidine and survival with colorectal cancer","volume":"340","author":"Matsumoto","year":"1995","journal-title":"Lancet"},{"key":"10.1016\/j.jss.2005.02.030_bib18","doi-asserted-by":"crossref","first-page":"990","DOI":"10.1016\/S0140-6736(88)90743-X","article-title":"Effect of cimetidine on survival after gastric cancer","volume":"2","author":"Tonnesen","year":"1988","journal-title":"Lancet"},{"key":"10.1016\/j.jss.2005.02.030_bib19","first-page":"183","article-title":"The effect of ranitidine on immune function, tumor response and survival in patients with liver metastases from colorectal cancer","volume":"1","author":"Nielsen","year":"1996","journal-title":"GI Cancer"},{"key":"10.1016\/j.jss.2005.02.030_bib20","doi-asserted-by":"crossref","first-page":"1768","DOI":"10.1016\/S0140-6736(94)92907-6","article-title":"Short course cimetidine and survival with colorectal cancer","volume":"344","author":"Adams","year":"1994","journal-title":"Lancet"},{"key":"10.1016\/j.jss.2005.02.030_bib21","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1002\/(SICI)1097-0142(19970701)80:1<15::AID-CNCR3>3.0.CO;2-E","article-title":"Pilot study","volume":"80","author":"Adams","year":"1997","journal-title":"Cancer"},{"key":"10.1016\/j.jss.2005.02.030_bib22","doi-asserted-by":"crossref","first-page":"1168","DOI":"10.1002\/bjs.1800840836","article-title":"Randomized controlled trial of an H2 receptor antagonist in gastric cancer","volume":"84","author":"Wotherspoon","year":"1997","journal-title":"Br. J. Surg."},{"key":"10.1016\/j.jss.2005.02.030_bib23","doi-asserted-by":"crossref","first-page":"1356","DOI":"10.1038\/sj.bjc.6690457","article-title":"Prospective, double blind, placebo controlled randomized trial of cimetidine in gastric cancer. British Stomach Cancer Group","volume":"81","author":"Langman","year":"1999","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.jss.2005.02.030_bib24","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1136\/gut.42.1.17","article-title":"A prospective randomized controlled study of the use of ranitidine in patients with gastric cancer. Yorkshire GI Tumor Group","volume":"42","author":"Primrose","year":"1998","journal-title":"Gut"},{"key":"10.1016\/j.jss.2005.02.030_bib25","first-page":"227","article-title":"The effect of ranitidine on long term survival in primary colorectal cancer. A 40 months interim analysis","volume":"2","author":"Nielsen","year":"1998","journal-title":"GI Cancer"},{"key":"10.1016\/j.jss.2005.02.030_bib26","doi-asserted-by":"crossref","first-page":"1416","DOI":"10.1046\/j.1365-2168.2002.02223.x","article-title":"Ranitidine as adjuvant treatment in colorectal cancer","volume":"89","author":"Nielsen","year":"2002","journal-title":"Br. J. Surg."},{"key":"10.1016\/j.jss.2005.02.030_bib27","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1080\/003655202317315971","article-title":"VEGF and tumor angiogenesis. Impact of surgery, wound healing, inflammation and blood transfusions","volume":"37","author":"Svendsen","year":"2002","journal-title":"Scand. J. Gastroenterol."},{"key":"10.1016\/j.jss.2005.02.030_bib28","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1097\/00000542-198803000-00017","article-title":"The possible immunosuppressive effects of perioperative blood transfusions in cancer patients","volume":"68","author":"Shiermer","year":"1988","journal-title":"Anesthesiology"},{"key":"10.1016\/j.jss.2005.02.030_bib29","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1002\/bjs.1800830236","article-title":"Time-dependent histamine release from stored human blood products","volume":"83","author":"Nielsen","year":"1996","journal-title":"Br. J. Surg."},{"key":"10.1016\/j.jss.2005.02.030_bib30","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1080\/028418602760169415","article-title":"Does famotidine enhance tumor infiltrating lymphocytes in breast cancer? Results of a randomized prospective pilot study","volume":"41","author":"Parshad","year":"2002","journal-title":"Acta Oncologica"},{"key":"10.1016\/j.jss.2005.02.030_bib31","first-page":"5","article-title":"In vitro augmentation of the cytotoxic activity of peripheral blood mononuclear cells and tumor infiltrating lymphocytes by famotidine in cancer patients","volume":"14","author":"Tsunoda","year":"1992","journal-title":"Int. J. Immunol."},{"key":"10.1016\/j.jss.2005.02.030_bib32","series-title":"The Pharmacological Basis of Therapeutics","first-page":"589","article-title":"Histamine and antihistamines","author":"Douglas","year":"1975"},{"key":"10.1016\/j.jss.2005.02.030_bib33","series-title":"AJCC Cancer Staging Manual","article-title":"AJCC Cancer Staging Manual","author":"Fleming","year":"1998"},{"key":"10.1016\/j.jss.2005.02.030_bib34","first-page":"211","article-title":"Role of histamine in tumor development","volume":"232","author":"Bartholeyns","year":"1985","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.jss.2005.02.030_bib35","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1038\/bjc.1981.99","article-title":"Increased tissue histamine in tumor bearing mice and rats","volume":"43","author":"Burtin","year":"1981","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.jss.2005.02.030_bib36","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1007\/BF00398182","article-title":"Blood histamine and solid malignant tumors","volume":"144","author":"Moriarty","year":"1988","journal-title":"J. Cancer Res. Clin. Oncol."},{"key":"10.1016\/j.jss.2005.02.030_bib37","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1210\/jcem-47-5-1038","article-title":"Elevated levels of polyamines and histamines in adenocarcinoma of thyroid","volume":"47","author":"Matsuzaki","year":"1978","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.jss.2005.02.030_bib38","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1007\/BF02004706","article-title":"Histamine content in human kidneys with hypernephroma. Is there a pathological mechanism?","volume":"11","author":"Reimann","year":"1981","journal-title":"Agents Actions"},{"key":"10.1016\/j.jss.2005.02.030_bib39","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/0046-8177(89)90180-9","article-title":"Prognostic significance of eosinophils and mast cells in rectal cancer","volume":"20","author":"Fisher","year":"1989","journal-title":"Hum. Pathol."},{"key":"10.1016\/j.jss.2005.02.030_bib40","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/0304-3835(87)90012-7","article-title":"Diamineoxidase activity and tissue histamine content of human skin, breast and rectal carcinoma","volume":"34","author":"Chanda","year":"1987","journal-title":"Cancer Lett."},{"key":"10.1016\/j.jss.2005.02.030_bib41","first-page":"639","article-title":"Involvement of histamine in growth of mouse and rat tumors. Antitumoral properties of monofluoromethyl histidine, an enzyme activated irreversible inhibitor of histidine decarboxylase","volume":"44","author":"Bartholeyns","year":"1984","journal-title":"Cancer Res."},{"key":"10.1016\/j.jss.2005.02.030_bib42","doi-asserted-by":"crossref","first-page":"389","DOI":"10.4049\/jimmunol.111.2.389","article-title":"Studies on the mechanisms of lymphocyte mediated cytolysis IV. Specificity of the histamine receptor on effector T cells","volume":"3","author":"Plaut","year":"1973","journal-title":"J. Immunol."},{"key":"10.1016\/j.jss.2005.02.030_bib43","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/0008-8749(89)90005-1","article-title":"Histamine regulates the generation of human cytolytic T lymphocytes","volume":"121","author":"Khan","year":"1989","journal-title":"Cell Immunol."}],"container-title":["Journal of Surgical Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022480405001058?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022480405001058?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,1,25]],"date-time":"2024-01-25T21:49:14Z","timestamp":1706219354000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022480405001058"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,12]]},"references-count":43,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2005,12]]}},"alternative-id":["S0022480405001058"],"URL":"https:\/\/doi.org\/10.1016\/j.jss.2005.02.030","relation":{},"ISSN":["0022-4804"],"issn-type":[{"value":"0022-4804","type":"print"}],"subject":[],"published":{"date-parts":[[2005,12]]}}}